Potential role of tinospora cordifolia in management of COVID-19
A systematic review
Keywords:
Phytochemicals, in silico studies, COVID 19Abstract
Background: Tinospora cordifolia has gained popularity as an immunomodulatory and protective herb. Being anIndian traditional herb, it has found its use in Ayurveda and alternative system of medicine. According to World Health Organization, still 80% of the world population relies on alternative therapies for disease and infirmity. Dearth of medicine and treatment for COVID-19 has pushed researcher towards alternative therapies. This review focuses on the potential role of T.cordifolia in management of Coronavirus disease. Methods:A systematic review has been carried out by searching Google Scholar and SCOPUS Database from the year 2020 onwards. The review is written following the PRISMA Guidelines. Results:A total of 20 studies have been included in the systematic review. These studies are mainly based on molecular docking (in-silico studies), narrative reviews, retrospective studies, animal experimentation and randomized controlled trials. All the studies reported promising results. In silico studies covered the activity of phytochemicals in T.cordifolia and their inhibitory action on viral replication and binding. The experimental studies also showed positive results in human as well as animal models.
Downloads
References
Adhikari B, Marasini BP, Rayamajhee B, Bhattarai BR, Lamichhane G, Khadayat K, Adhikari, A, Khanal S, & Parajuli N. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phytotherapy research. 2021: 35(3), 1298–1312. https://doi.org/10.1002/ptr.6893
Ansary PY and Sudhikumar. KB. Pharmacological Potential of Guduchyadi Kwatham in Combating COVID-19. International Journal of Ayurveda and Pharma Research. 2020;8(6):9-22.
Badri K, Aramgam S, et al. Efficacy of Tinospora cordifolia in treating SARS-CoV-2: in silico studies. The FASEB Journal. 2021: 35. https://doi.org/10.1096/fasebj.2021.35.S1.04976
Balkrishna A, Khandrika L, Varshney A. Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish. Front Pharmacol. 2021;12:635510. Published 2021 Apr 19. doi:10.3389/fphar.2021.635510
Balkrishna A, Pokhrel S, Varshney A. Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain. Comb Chem High Throughput Screen. 2021;24(10):1795-1802. doi:10.2174/1386207323666201110152615
Bharathi C, Aswartha HR, et al. A Review on Medicinal Properties of Tinospora cordifolia. International Journal of Scientific Research and Review. 2018.
Bishayi B, Roychowdhury S, Ghosh S, Sengupta M. Hepatoprotective and immunomodulatory properties of Tinospora cordifolia in CCl4 intoxicated mature albino rats. J Toxicol Sci. 2002;27(3):139-146. doi:10.2131/jts.27.139
Chen Y, Liu Q & Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of medical virology. 2020: 92(4), 418–423. https://doi.org/10.1002/jmv.25681
Chowdhury P. In silico investigation of phytoconstituents from Indian medicinal herb 'Tinospora cordifolia (giloy)' against SARS-CoV-2 (COVID-19) by molecular dynamics approach. Journal of biomolecular structure& dynamics. 2021: 39(17), 6792–6809. https://doi.org/10.1080/07391102.2020.1803968
Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Micro. 2020;5: 536–544.
Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Le infezioni in medicina. 2020;28(suppl 1):6–17.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
Jena S, Munusami P, Mm B, Chanda K. Computationally approached inhibition potential of Tinospora cordifolia towards COVID-19 targets [published online ahead of print, 2021 Mar 20]. Virusdisease. 2021;32(1):1-13. doi:10.1007/s13337-021-00666-7
Jin Z, Du X, Xu Y, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582(7811):289-293. doi:10.1038/s41586-020-2223-y
Kavita V, Anubha C, et al. An Open label prospective interventional study to assess the prophylactic effect of Guduchi Ghan Vati in COVID-19: A community-based study in a containment zone of Himachal Pradesh, India. 2021. https://doi.org/10.31219/osf.io/8vwsy
Khan Mujahid and Rathi Bharat. Tinospora Cordifolia-An immunomodulatory drug in Ayurveda for prevention and treatment of Covid-19. International Journal of Research in Pharmaceutical Sciences. 2020: 11, 1695-1699. 10.26452/ijrps.v11iSPL1.4194.
Krupanidhi S, Abraham Peele K, Venkateswarulu TC, et al. Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study. J Biomol Struct Dyn. 2021;39(15):5799-5803. doi:10.1080/07391102.2020.1787226
Kumar Abhimanyu & Prasad Govind, et al. A Retrospective Study on Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients. MedRXIV. 2020. 10.1101/2020.07.23.20160424.
Kumar Abhimanyu, Prasad Govind, et al. Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection: An Open Label Feasibility Study. 2020. 10.1101/2020.09.20.20198515.
Manne M, Goudar G, Varikasuvu SR, et al. Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α. 3 Biotech. 2021;11(3):136. doi:10.1007/s13205-021-02685-z
Merta, I. N., & Suderana, I. W. (2020). COVID-19 pandemic handling community social and cultural sector stimulus efforts. International Journal of Social Sciences and Humanities, 4(3), 1–12. https://doi.org/10.29332/ijssh.v4n3.434
Mishra B. Immunological effect of Amritadi Kwath for improving immunity to fight covid -19 pandemic. World Journal of Pharmaceutical Research. 2020. Volume 9:9. 1070-1080.
Modi B & Shah K, et al. Morphology, Biological Activity, Chemical Composition, and Medicinal Value of Tinospora Cordifolia (willd.) Miers. Advanced Journal of Chemistry. 2020. 10.22034/ajcb.2020.243751.1058.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. Published 2015 Jan 1. doi:10.1186/2046-4053-4-1
Murugesan S, Kottekad S, Crasta I, Sreevathsan S, Usharani D, Perumal MK, & Mudliar S N. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study. Computers in biology and medicine. 2021:136, 104683. https://doi.org/10.1016/j.compbiomed.2021.104683
Patil AM, Gothert JR, Khairnar V. Emergence, transmission, and potential therapeutic targets for the COVID-19 pandemic associated with the SARS-CoV-2. Cellul Physiol Biochem Int J Exp Cellula Physiol Biochem Pharmacol. 2020;54(4):767–90. https://doi.org/10.33594/000000254.
Rodríguez-Morales AJ, MacGregor K, Kanagarajah S., Patel D, & Schlagenhauf, P. Going global – Travel and the 2019 novel coronavirus. Travel Medicine and Infectious Disease. 2020: 33. 101578. https://doi.org/10.1016/j.tmaid.2020.101578
Sagar Vasanthkumar & Kumar Arun. Efficacy of Natural Compounds from Tinospora cordifolia Against SARS-CoV-2 Protease, Surface Glycoprotein and RNA Polymerase. Biology, Engineering, Medicine and Science Reports. 2020: 6, 6-8. 10.5530/bems.6.1.2.
Sanjeev Rastogi, Deep Narayan Pandey, Ram Harsh Singh. COVID-19 pandemic: A pragmatic plan for ayurveda intervention. Journal of Ayurveda and Integrative Medicine. 2020. ISSN 0975-9476, https://doi.org/10.1016/j.jaim.2020.04.002.
Sharma U, Bala M, Kumar N, Singh B, Munshi RK, Bhalerao S. Immunomodulatory active compounds from Tinospora cordifolia. J Ethnopharmacol. 2012;141(3):918-926. doi:10.1016/j.jep.2012.03.027
Shukla U, Ujjaliya N, et al. Efficacy and safety of Guduchighan Vati in asymptomatic and mild to moderate cases of COVID-19: A randomized controlled pilot study. Medrixv. 2021. https://doi.org/10.31219/osf.io/c8f9h
Sinaei R, Pezeshki S, Parvaresh S, Sinaei R. Why COVID-19 is less frequent and severe in children: a narrative review. World J Pediatr. 2020;17(1):10-20. doi:10.1007/s12519-020-00392-y
Singh A, Singh RS, Sarma P, Batra G, Joshi R, Kaur H, et al. A comprehensive review of animal models for coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virol Sin. 2020;35(3):290–304. https://doi.org/10.1007/s12250-020-00252-z
Singh MP. Giloy as immunity booster in COVID 19 pandemic disease. World Journal of Pharmaceutical Research. 2020. Volume 9: 15. 1065-1078.
Singh R. Giloy (Tinospora cordifolia): exploring its therapeutic potential. International Journal of Research and Analytical Reviews. 2019:2, 988-995.
Sonkamble V and Kamble H. Antidiabetic potential and identification of phytochemicals from Tinospora cordifolia. American Journal of Phytomedicine and Clinical Therapeutics. 2015. 97–110.
Sonkamble VV& Kamble LH. Antidiabetic potential and identification of phytochemicals from Tinospora cordifolia. American Journal of Phytomedicine and Clinical Therapeutics. 2015:3, 97–110.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Thakar Anup, Panara Kalpesh,et al. Guduchi Ghanavati to Improve Immune Status and General Health in the Population at High Risk of COVID-19: Results of An Open-Label Non-Randomized Clinical Trial from India. 2021. Available at SSRN: https://ssrn.com/abstract=3798254 or http://dx.doi.org/10.2139/ssrn.3798254
Thakkar SS, Shelat F and Thakor P. Magical bullets from an indigenous Indian medicinal plant Tinospora cordifolia: An in silico approach for the antidote of SARS-CoV-2. Egyptian Journal of Petroleum. 2021: 30(1), 53–66. https://doi.org/10.1016/j.ejpe.2021.02.005
Thatte UM, Rao SG and Dahanukar SA. Tinospora cordifolia induces colony stimulating activity in serum. Journal of Postgraduate Medicine. 1994, 40: 202- 203.
Thorat V, Tamboli FA, Jadhav A, Gaikwad R and Rangari D. Role of Tinospora cordifolia as immune booster current covid -19 pandemic. Int J Pharmacognosy. 2020; 8(8): 307-15. http://dx.doi.org/10.13040/IJPSR.0975-8232.IJP.8(8).307-15.
Varpe SP, Balme VS, et al. Tinospora cordifolia-an immunomodulatory drug in ayurveda for prevention and treatment of COVID-19 and diverse pharmacological importance. World Journal of Pharmaceutical Research. 2021. Volume 10:6. 1734-1747.
Widjaja, G. (2021). Impact of human resource management on health workers during pandemics COVID-19: systematic review. International Journal of Health & Medical Sciences, 4(1), 61-68. https://doi.org/10.31295/ijhms.v4n1.850
Yang Z, Lasker K, Schneidman-Duhovny D, et al. UCSF Chimera, MODELLER, and IMP: an integrated modeling system. J Struct Biol. 2012. 179;(3). 269-78.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
